May 19, 2022

Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca 

PDF icon
EN PDF icon
NL
May 3, 2022

Biotalys Obtains New Fungicide Resistance Class for its First Biofungicide

PDF icon
EN PDF icon
NL
April 29, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
April 18, 2022

Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors

PDF icon
EN PDF icon
NL
April 15, 2022

Results of the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN PDF icon
NL
March 31, 2022

Biotalys Appoints Carlo Boutton as Chief Scientific Officer

PDF icon
EN PDF icon
NL
March 15, 2022

Invitation to the Annual and Extraordinary Shareholders’ Meetings

PDF icon
EN PDF icon
NL
March 11, 2022

Biotalys Reports Full Year 2021 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
February 15, 2022

Notice of Full Year 2021 Results and Business Highlights

PDF icon
EN PDF icon
NL
January 31, 2022

Information on the total number of voting rights and shares

PDF icon
EN PDF icon
NL
January 27, 2022

Biotalys Appoints Kwizda Agro as Formulator of Its Protein-Based Biocontrols

PDF icon
EN PDF icon
NL
January 25, 2022

Biotalys Achieves Breakthrough in Protein Expression Increasing Commercial Potential for its first BioFungicide Evoca

PDF icon
EN PDF icon
NL
January 12, 2022

Biotalys and Olon Enter into Long-Term Partnership for the Production of Protein-Based Biocontrols

PDF icon
EN PDF icon
NL
December 17, 2021

Biotalys and Biobest Enter into Strategic Partnership to Expand Reach of Novel Biocontrol Solutions

PDF icon
EN PDF icon
NL
November 15, 2021

Biotalys’ first biocontrol Evoca™ demonstrated to be an excellent new tool for growers in 2021 independent field trials

PDF icon
EN PDF icon
NL